Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $11.9 million.

  • Immucell's Total Non-Current Liabilities fell 1208.41% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 1208.41%. This contributed to the annual value of $13.2 million for FY2024, which is 990.26% down from last year.
  • Latest data reveals that Immucell reported Total Non-Current Liabilities of $11.9 million as of Q3 2025, which was down 1208.41% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, Immucell's Total Non-Current Liabilities registered a high of $15.2 million during Q3 2023, and its lowest value of $9.4 million during Q4 2021.
  • For the 5-year period, Immucell's Total Non-Current Liabilities averaged around $12.0 million, with its median value being $11.9 million (2025).
  • Per our database at Business Quant, Immucell's Total Non-Current Liabilities skyrocketed by 2990.01% in 2023 and then plummeted by 1208.41% in 2025.
  • Over the past 5 years, Immucell's Total Non-Current Liabilities (Quarter) stood at $9.4 million in 2021, then rose by 21.96% to $11.4 million in 2022, then grew by 28.13% to $14.6 million in 2023, then decreased by 9.9% to $13.2 million in 2024, then fell by 9.41% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $12.4 million for Q2 2025, and $12.8 million during Q1 2025.